X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

Sonoco ThermoSafe Introduces the Pegasus ULD line of Passive Temperature Controlled Unit Load Devices

Content Team by Content Team
17th September 2019
in Packaging & Logistic, Press Statements
Sonoco ThermoSafe

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Sonoco ThermoSafe announced the creation of the Pegasus ULD® line of passive temperature controlled unit load devices.  The Pegasus ULD will be the first passive bulk temperature-controlled container for pharmaceutical use that is an approved unit load device, which allows it to speed through existing international ground handling and customs processes at the lowest possible cost.

With increasing demands for life science and healthcare companies to ship in larger quantities, the Pegasus ULD was specifically designed to fulfill a gap in the market for passive bulk packaging solutions. Engineered with composite materials, the unit load device will offer a lighter solution that is substantially more damage-resistant than traditional metal containers. Additionally, Sonoco ThermoSafe customers will experience cutting edge integrated real-time data capabilities, including internal and external temperature tracking and robust geolocation. Because risk mitigation decisions are based on accurate and timely data, Pegasus ULD users will be able to count on these capabilities when they need them the most.

To create the Pegasus ULD, Sonoco ThermoSafe signed a long-term exclusive development and manufacturing agreement with AEROTUF, a leading supplier of innovative composite ULD containers (www.aerotuf.com).  The partnership combines ThermoSafe’s expertise in thermal engineering and pharmaceutical logistics with AEROTUF’s materials science and aeronautical engineering capabilities. The first Pegasus ULD model, to be launched in the upcoming months, will be the lighter AKP size, which fits a full US pallet and shares the same footprint of the AKE size without the imbalanced overhang section which accounts for over 80% of transit damage in AKE/RKN containers.

“We are delighted to partner with AEROTUF to create the best-in-class Pegasus ULD® line of passive temperature control ULD containers,” said Christopher Day, Director of Marketing, Innovation and Business Development for Sonoco ThermoSafe. “The rugged, lightweight composite design of this unit load device enables the pharmaceutical supply chain to cost-effectively ship globally across the Americas, EMEIA and Asia-Pacific regions. Additionally, Sonoco’s 300+ global locations allow the ThermoSafe division to quickly and efficiently expand the depot network for leasing Pegasus ULD® units across the globe.”

Additional announcements about the Pegasus ULD, including airline approvals and updates to the global service network, will be forthcoming. Please contact your Sonoco ThermoSafe representative or visit www.thermosafe.com/contact for more information.

Previous Post

Mallinckrodt Agrees to Sell BioVectra Inc. to H.I.G. Capital for $250 Million

Next Post

VNUE AP, hand in hand with TCELS and the Science and Technology Trade Association,to organize Thailand LAB INTERNATIONAL and Bio Investment Asia 2019

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
Future Trends Shaping
Packaging & Logistic

Future Trends Shaping Pharma Supply Chain and Logistics

30th July 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Next Post
Thailand LAB INTERNATIONAL and Bio Investment Asia 2019

VNUE AP, hand in hand with TCELS and the Science and Technology Trade Association,to organize Thailand LAB INTERNATIONAL and Bio Investment Asia 2019

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In